Skip to main content
Carlos Arteaga, MD, Oncology, Dallas, TX, UT Southwestern Zale Lipshy Hospital

CarlosL.ArteagaMD

Oncology • Dallas, TX

Breast Cancer, Hematologic Oncology

Professor and Director, UT Southwestern Medical Center Harold C. Simmons Comprehensive Cancer Center

Join to view full profile

Dr. Arteaga is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Arteaga's full profile

Already have an account?

Summary

  • Dr. Carlos L. Arteaga is the Director of the Harold C. Simmons Comprehensive Cancer Center and Associate Dean of Oncology Programs at UT Southwestern Medical Center.

    Dr. Arteaga earned his medical degree at the University of Guayaquil in Ecuador. He trained in internal medicine and medical oncology at Emory University and the University of Texas Health Science Center at San Antonio. He joined Vanderbilt University Medical Center in 1989, where he held the Donna S. Hall Chair in Breast Cancer Research and served at the Vanderbilt-Ingram Cancer Center (VICC) as Director of the Center for Cancer Targeted Therapies, the Director of the Breast Cancer Program, and the Associate Director for Translational/Clinical Research until 2017, when he joined UT Southwestern.

    Dr. Arteaga has more than 300 publications in the areas of oncogenes and breast tumor initiation and progression, development of targeted therapies and biomarkers of drug action and resistance, and investigator-initiated clinical trials in breast cancer. His research is or has been funded by the National Cancer Institute (NCI), CPRIT, the American Cancer Society, the Department of Defense Breast Cancer Research Program, Stand Up 2 Cancer (SU2C), and the Susan G. Komen for the Cure and Breast Cancer Research foundations.

    During his career, Dr. Arteaga has received several awards, including the American Association for Cancer Research-Richard and Hinda Rosenthal Award, the American Cancer Society Clinical Research Professor Award, the Gianni Bonadonna Award from the American Society of Clinical Oncology, the Brinker Award for Scientific Distinction from the Susan G. Komen Foundation, the 2015 Prize for Scientific Excellence in Medicine from the American-Italian Cancer Foundation, and the Clinical Investigator Award from the U.S. Department of Veteran Affairs.

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1984 - 1988
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 1980 - 1984
  • Universidad de Guayaquil, School of Medicine.
    Universidad de Guayaquil, School of Medicine.Class of 1979

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2018 - 2025
  • TN State Medical License
    TN State Medical License 1989 - 2018
  • GA State Medical License
    GA State Medical License 1982 - 1989
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Elected Member The American Society for Clinical Investigation, 1999
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Capivasertib in Patients with an AKT1 E17K-Mutated Tumor  
    Kevin Kalinsky, Edith P Mitchell, Barbara A Conley, Lyndsay N Harris, Carlos L Arteaga, Alice P Chen, Keith T Flaherty, JAMA Oncology

Lectures

  • 35th Annual San Antonio Breast Cancer Symposium 
    UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
  • 34th Annual San Antonio Breast Cancer Symposium 
    UT Health Science Center San Antonio, San Antonio, Texas - 12/6/2011

Authored Content

  • Buparlisib plus Fulvestrant Versus Placebo plus Fulvestrant for Postmenopausal, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, Advanced Breast Cancer: Overall Survival Results from BELLE-2October 2018

Press Mentions

  • Noted Dallas Researcher, Physician Named as Susan G. Komen Research Scholar
    Noted Dallas Researcher, Physician Named as Susan G. Komen Research ScholarMay 5th, 2023
  • $20 Million in CPRIT Cancer Research Funds Heading to North Texas
    $20 Million in CPRIT Cancer Research Funds Heading to North TexasMarch 17th, 2023
  • Pausing Long-Term Breast Cancer Therapy to Become Pregnant Appears to Be Safe
    Pausing Long-Term Breast Cancer Therapy to Become Pregnant Appears to Be SafeJanuary 20th, 2023
  • Join now to see all

Grant Support

  • ERBB2 Targeted Antitumor Strategies In Breast CancerNational Cancer Institute1999–2012
  • Vanderbilt Training Program In Academic Cancer ResearchNational Cancer Institute2010–2011
  • Resistance To Antiestrogen Therapy In Hormone Receptor-Positive Breast CancerNational Cancer Institute2008–2011
  • Developmental Research ProgramNational Cancer Institute2008–2011
  • Career Development ProgramNational Cancer Institute2008–2011
  • Administrative And Outreach CoreNational Cancer Institute2008–2011
  • Spore In Breast CancerNational Cancer Institute2003–2011
  • Tgf-Betas And Receptors And Human Breast CellsNational Cancer Institute1999–2009
  • Training Program In Breast Cancer ResearchNational Cancer Institute2001–2007
  • Her(Erbb) Inhibitors In Untreated Operable Breast CancerNational Cancer Institute2004
  • Role Of Tgfb-Isoforms In Human Breast Epithelial CellsNational Cancer Institute1995–1998
  • Phase I Study Antisense FOS Vector In Breast CancerNational Cancer Institute1996–1997

Professional Memberships

Hospital Affiliations

External Links

  • UT Southwesternhttp://profiles.utsouthwestern.edu/profile/146478/carlos-arteaga-biography.html

Dr. Carlos Arteaga, Dr. Carlos Arteaga, MD, Dr. C Arteaga, Dr. Carlos L. Arteaga